Revenue declined 13% year-over-year in Q2 2024, but EBITDA loss narrowed due to efficiency gains and reduced one-time costs. R&D pipeline grew, new business models advanced, and cash flow improved despite ongoing macroeconomic uncertainty.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.